Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

BACKGROUND: We explored, within the EORTC10994 study, the outcomes for patients with molecular apocrine (MA) breast cancer, and defined immunohistochemistry (IHC) as androgen-receptor (AR) positive, oestrogen (ER) and progesterone (PR) negative. We also assessed the concordance between IHC and gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnefoi, Hervé, MacGrogan, Gaetan, Poncet, Coralie, Iggo, Richard, Pommeret, Fanny, Grellety, Thomas, Larsimont, Denis, Bécette, Véronique, Kerdraon, Olivier, Bibeau, Frédéric, Ghnassia, Jean-Pierre, Picquenot, Jean-Michel, Thomas, Jeremy, Tille, Jean-Christophe, Slaets, Leen, Bodmer, Alexandre, Bergh, Jonas, Cameron, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734658/
https://www.ncbi.nlm.nih.gov/pubmed/30899086
http://dx.doi.org/10.1038/s41416-019-0420-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734658/
https://www.ncbi.nlm.nih.gov/pubmed/30899086
http://dx.doi.org/10.1038/s41416-019-0420-y

Ejemplares similares